Global measles and rubella strategic plan, 2012-2020
Corporate Authors:World Health Organization ; American National Red Cross ; Centers for Disease Control and Prevention (U.S.) ; ... More ▼
Prevention & Control
Public Health Surveillance
Rubella Syndrome, Congenital
Disease Outbreaks/Prevention & Control
Measles/Prevention & Control
Measles Vaccine/International Cooperation
MMR Vaccine/International Cooperation
Rubella/Prevention & Control
Rubella Syndrome, Congenital/Prevention & Control
Rubella Vaccines/International Cooperation
Description:Abbreviations and acronyms -- Foreword -- Executive summary -- Introduction -- Vision, goals and milestones -- Global context -- Measles vaccination -- Rubella vaccination -- Laboratory network -- Current WHO global and regional targets -- Potential future WHO global targets -- Recent setbacks and risk of resurgence -- Economic analyses of measles, rubella and CRS control and elimination -- Strategy to eliminate measles, rubella and CRS -- 1. Achieve and maintain high levels of population immunity by providing high vaccination coverage with two doses of measles- and rubella-containing vaccines -- 2. Monitor disease using effective surveillance and evaluate programmatic efforts to ensure progress -- 3. Develop and maintain outbreak preparedness and respond rapidly to outbreaks and manage cases -- 4. Communicate and engage to build public confidence and demand for immunization -- 5. Perform the research and development needed to support cost-effective operations and improve vaccination and diagnostic tools -- Guiding principles to eliminate measles, rubella and CRS -- 1. Country ownership and sustainability -- 2. Routine immunization and health systems strengthening -- 3. Equity -- 4. Linkages -- Challenges to implementing the Strategic Plan -- 1. Financial risks -- 2. High population density and highly mobile populations -- 3. Weak immunization systems and inaccurate reporting of vaccination coverage -- 4. Managing perceptions and misperceptions -- 5. Confiict and emergency settings -- Roles and responsibilities -- 1. National governments -- 2. Global and regional partners -- The Measles and Rubella Initiative -- The GAVI Alliance -- Tracking progress -- Conclusion -- References -- Annex 1. List of measles and rubella priority countries.
This Strategic Plan 2012–2020 explains how countries, working together with the MR Initiative and its partners, will achieve a world without measles, rubella and congenital rubella syndrome (CRS). The Plan builds on the experience and successes of a decade of accelerated measles control efforts that resulted in a 74% reduction in measles deaths globally between 2000 and 2010 (1). It integrates the newest 2011 World Health Organization (WHO) policy on rubella vaccination which recommends combining measles and rubella control strategies and planning efforts, given the shared surveillance and widespread use of combined measles-rubella vaccine formulations, i.e. measles-rubella (MR) and measles-mumps-rubella (MMR). The Plan presents clear strategies that country immunization managers, working with domestic and international partners, can use as a blueprint to achieve the 2015 and 2020 measles and rubella control and elimination goals. The strategy focuses on the implementation of five core components. 1. Achieve and maintain high levels of population immunity by providing high vaccination coverage with two doses of measles- and rubella-containing vaccines. 2. Monitor disease using effective surveillance, and evaluate programmatic efforts to ensure progress. 3. Develop and maintain outbreak preparedness, respond rapidly to outbreaks and manage cases. 4. Communicate and engage to build public confidence and demand for immunization. 5. Perform the research and development needed to support cost-effective operations and improve vaccination and diagnostic tools. The Plan provides the global context and an assessment of the current state of the world with respect to national, regional and global management of measles and rubella. It outlines guiding principles that provide a foundation for all measles and rubella control efforts, including country ownership, strengthening routine immunization and health systems, ensuring linkages with other health interventions and providing equity in immunization by reaching every child. Given the progress made to date, the plan includes a list of priority countries that require additional support to meet regional and global goals. It also examines key challenges to measles and rubella control and elimination, including: financial risks; high population density and highly mobile populations; weak immunization systems and inaccurate reporting of vaccination coverage; managing perceptions and misperceptions; and conflict and emergency settings. The Plan offers solutions to these challenges, discusses the roles and responsibilities of stakeholders, and provides indicators to monitor and evaluate national, regional and global progress towards the vision and goals. Countries bear the largest responsibility for measles and rubella control and elimination, and they must support sustainable national planning, funding and advocacy to protect their citizens from devastating preventable diseases. The MR Initiative and its five spearheading partners — the American Red Cross, United States Centers for Disease Control and Prevention, United Nations Children’s Fund, United Nations Foundation and World Health Organization — endorse this Strategic Plan and will work with countries and international donors on its implementation. As countries work towards attaining national, regional and global measles, rubella and CRS control and elimination goals, they can rely on technical and financial support from the MR Initiative and its partners, including the GAVI Alliance (formerly the Global Alliance for Vaccines and Immunization). To support this Plan, the MR Initiative developed and maintains a Financial Resource Requirements document that it reviews and updates regularly. The MR Initiative recommends that all stakeholders use this Plan and the referenced technical guidance to secure the commitments and actions required for a world free of measles, rubella and CRS.
Supporting Files:No Additional Files
You May Also Like: